Climb Bio, Inc. ( CLYM) - Stock Earnings
CLYM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -17.5 million USD | — USD |
| 2026Q1 | -13.7 million USD | — USD |
| 2026Q2 | -13.5 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
CLYM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -35.1 million USD | — USD |
| 2024 | -73.9 million USD | — USD |
| 2025 | -59.9 million USD | — USD |
| 2026 Est. | — | — |
CLYM
Price: $17.02
52 week price:
Earnings Per Share: -0.82 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 937.9 million